Physician profile
Rajeev Narang
NPI 1700894359
$106,092.18
in general payments reported to CMS, 2019-2025
44 companies · $2,935 in 2025
The $2,935 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $15K · 2021: $21K · 2022: $20K · 2023: $8,970 · 2024: $13K · 2025: $2,935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $5,634 · Education: $4,961 · Travel and Lodging: $3,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,075.00 |
| Food and Beverage | $5,634.16 |
| Education | $4,960.68 |
| Travel and Lodging | $3,915.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $56,721.80 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $14,769.48 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13,609.81 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Intuitive Surgical, INC. | $8,039.74 | 2022-2025 | |
| Viiv Healthcare Company | $4,000.00 | 2019 | |
| Inspire Medical Systems, INC. | $2,426.81 | 2023-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $1,068.99 | 2019-2025 | Uptravi, Opsumit |
| Mylan Specialty L.P. | $953.14 | 2019-2024 | Yupelri |
| Insmed, INC. | $699.18 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $595.23 | 2019-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $400.90 | 2020-2025 | |
| Sunovion Pharmaceuticals INC. | $318.67 | 2019 | |
| Pulmonx Corporation | $248.11 | 2022-2024 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Merck Sharp & Dohme LLC | $213.46 | 2023-2025 | Winrevair, Keytruda |
| Grifols USA, LLC | $209.95 | 2019-2024 | Prolastin-C Liquid |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $199.33 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $152.99 | 2024-2025 | Dupixent |
| Gilead Sciences, INC. | $146.06 | 2019-2021 | |
| Electromed, INC. | $138.11 | 2022-2025 | Smartvest |
| Philips North America LLC | $136.93 | 2019-2025 | Respiratory, (O58) Sleep Respiratory Care Und |
| Galvanize Therapeutics, INC | $129.53 | 2025 | Aliya System |
| Chiesi USA, INC. | $97.32 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.65 | 2020-2024 | Aralast |
| Mallinckrodt Hospital Products INC. | $76.29 | 2021-2024 | Acthar |
| Genentech USA, INC. | $70.15 | 2019-2023 | Xolair |
| Paratek Pharmaceuticals, INC. | $64.12 | 2019-2023 | Nuzyra |
| Amgen INC. | $51.71 | 2024-2025 | Tavneos |
| Verona Pharma, INC. | $46.47 | 2025 | Ohtuvayre |
| Melinta Therapeutics, LLC | $44.45 | 2019-2022 | |
| Baxter Healthcare | $42.28 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Zoll Respicardia, INC. | $39.38 | 2025 | Remede System |
| Tactile Systems Technology INC | $34.51 | 2022 | |
| Harmony Biosciences LLC | $33.39 | 2022 | |
| Veran Medical Technologies, INC. | $31.58 | 2019-2020 | |
| Shire North American Group INC | $29.66 | 2019 | |
| Alk-Abello, INC | $25.89 | 2024 | Grastek, Ragwitek, Odactra |
| 3b Medical, INC. | $25.08 | 2025 | Luna |
| Bayer Healthcare Pharmaceuticals INC. | $22.32 | 2022 | |
| Viatris Specialty LLC | $21.34 | 2025 | Yupelri |
| Apria Healthcare LLC | $21.20 | 2021 | |
| Pfizer INC. | $17.88 | 2024 | |
| Portola Pharmaceuticals, LLC | $15.50 | 2019 | |
| Ani Pharmaceuticals, INC. | $13.57 | 2023 | Purified Cortrophin Gel |
| Vifor Pharma, INC. | $13.22 | 2024 | Veltassa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Narang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.